Free Testosterone (Free T)
Free testosterone represents the unencumbered, non-protein-bound fraction of testosterone immediately capable of diffusing across cellular membranes to activate the androgen receptor.
Standard vs. Optimal Reference Rangesng/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
5.0 - 21.0 ng/dL (or 50 - 210 pg/mL)
General reference distribution across unselected commercial populations.
15.0 - 25.0 ng/dL (Equilibrium Dialysis)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Free testosterone diffuses into target cells, binds the cytoplasmic androgen receptor (AR), translocates to the nucleus, and binds androgen response elements (AREs) to transcribe anabolic and metabolic genes.
Differential Diagnosis
Elevated Levels (Free T High)
- •Exogenous androgen therapy
- •Low SHBG states (severe insulin resistance)
Low Levels (Free T Low)
- •Elevated SHBG (aging, hyperthyroidism, caloric restriction)
- •Clinical hypogonadism
- •Chronic systemic illness and inflammation
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Blood draw must occur strictly between 7:00 AM and 9:00 AM to account for steep circadian cortisol and testosterone peaks. Ensure 8 hours of restful sleep prior; night shift work or sleep deprivation severely blunts endocrine pulsatility. Discontinue biotin supplements for 72 hours before thyroid or steroid testing to prevent false immunoassay results. For reproductive hormones in premenopausal females, precisely document the day of the menstrual cycle (Day 3 for baseline follicular, Day 21 for luteal).
Reflexive Testing Protocol:
- Free Hormone Equilibrium Dialysis or LC-MS/MS assay for direct bioavailable hormone quantification
- Pituitary trophic hormone panel (TSH, LH, FSH, ACTH, Prolactin) to differentiate primary vs central secondary endocrinopathies
- Autoantibody quantification (Thyroid Peroxidase Antibodies, Thyroglobulin Antibodies, 21-Hydroxylase Antibodies)
- Pelvic, testicular, or thyroid high-resolution ultrasound imaging to assess glandular parenchymal architecture
- Dynamic endocrine stimulation testing (Cosyntropin/ACTH stimulation test, Dexamethasone suppression test, GnRH test)
Clinical Citations & Primary Literature (1)
- [1]Measurement and Clinical Significance of Free Testosterone in Men - Lancet Diabetes & Endocrinology (2022). PMID: 35196412
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Free Testosterone (Free T) into overall healthspan optimization.